Plasma membrane calcium-transporting ATPase (PMCA)

Plasma membrane calcium-transporting ATPase (PMCA) is a **P-type ATPase enzyme** responsible for the active export of Ca2+ from the cytoplasm to the extracellular space, thereby tightly maintaining low intracellular calcium levels essential for cell signaling, viability, and function[1][2][7]. PMCA uses the energy from ATP hydrolysis to pump Ca2+ ions across the plasma membrane, playing a central role in neuronal excitability, muscle contraction, cell growth, and apoptosis[2][7]. Multiple isoforms (PMCA1-4) are encoded by distinct genes and are expressed in a tissue- and cell type-specific fashion, with important physiological and pathological implications[2][7]. Dysfunction or genetic mutations in specific isoforms are associated with neurodegenerative diseases, hearing impairment, infertility, and possibly cardiovascular and other disorders[2][7]. Although currently not the target of clinically available drugs, PMCA remains a biologically and potentially therapeutically important enzyme and transporter in human health and disease[2][7].

Other names

Plasma membrane Ca2+ ATPasePlasma membrane calcium pumpCa2+-ATPase (when referring to PMCA specifically)PMCA (with isoforms PMCA1/ATP2B1, PMCA2/ATP2B2, PMCA3/ATP2B3, PMCA4/ATP2B4)P-type ATPase (subcategory: P2B-ATPases)

Direct inhibition or activation is rare; most modulation occurs via calmodulin binding (activates PMCA at high Ca2+), phosphorylation, alternative splicing, or post-translational modifications[2][7]. Calcium transport via ATP hydrolysis: The enzyme pumps Ca2+ out of the cytoplasm in exchange for ATP hydrolysis, reducing cytosolic Ca2+ concentration[2][3][5][7].